Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Dana-Farber Cancer Institute
Related studies linked through entity extraction aliases.
Immuno-Oncology Drugs Elotuzumab, Anti-LAG-3 and Anti-TIGIT
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Videos for Advance Care Planning in Young Adults
- Status
- COMPLETED
- Phase
- NA
A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Palbociclib + Ganitumab In Ewing Sarcoma
- Status
- TERMINATED
- Phase
- PHASE2
Smart Phone App Intervention In Young Adults With Cancer
- Status
- COMPLETED
- Phase
- NA
Abemaciclib + Pembrolizumab In Glioblastoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Stereotactic Magnetic Resonance Guided Radiation Therapy
- Status
- RECRUITING
- Phase
- NA
LY3214996 in Patients With AML Who Are Not Candidates for Standard Therapy
- Status
- COMPLETED
- Phase
- PHASE1
Topical Tazarotene Vs Placebo In Hand-Foot-Skin Reactions
- Status
- TERMINATED
- Phase
- PHASE2
OPTimizing Treatment Focused Genetic Testing IN Cancer
- Status
- COMPLETED
- Phase
- NA
A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma
- Status
- RECRUITING
- Phase
- NA
ERK 1/2 Signaling in Ibrutinib Resistant B-cell Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE1
Rogaratinib for BCG Refractory High Risk Non-Muscle Invasive Bladder Cancer With FGFR1/2 Overexpression
- Status
- WITHDRAWN
- Phase
- PHASE2
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
- Status
- RECRUITING
- Phase
- NA
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
- Status
- RECRUITING
- Phase
- NA
Understanding Chronic Lymphocytic Leukemia
- Status
- RECRUITING
- Phase
- N/A
NeoVax With Nivolumab in Patients With Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE1
A Phase II Trial of Neoadjuvant Treatment With PD-1 Inhibition (Nivolumab) With or Without IDO Inhibition (BMS-986205) and With or Without CTLA-4 Inhibition (Ipilimumab) in Resectable Stage III or IV Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE2